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Purpose
Hypergammaglobulinemia in adult patients is usually
related to malignancy, autoimmune disease, or infection.
The differential diagnosis of hypergammaglobulinemia in
children has not been similarly well defined. Malignancies
and autoimmunity are much less common in children
compared to the adult population, and therefore the impli-
cations of an elevated immunoglobulin in a pediatric
patient are less clear. We therefore sought to establish the
differential diagnosis of hypergammaglobulinemia in chil-
dren through a retrospective cohort analysis.
Methods
The Children’s Hospital Boston laboratory database was
queried for all in- and out-patients with IgG levels ≥2000
mg/dL measured from 2000-2009. Charts were reviewed
and patient characteristics, associated laboratory findings,
diagnoses and outcomes were extracted. A random sam-
pling of 10% of the patients was analyzed in detail.
Results
A total of 1519 instances of IgG levels ≥2000 mg/dL
belonging to 748 individual patients were identified. Of
these, 85 patients were analyzed in detail. Thirty-one
(36.5%) were excluded because they had received IVIG
within one month prior to the abnormal test result.
Indications for IVIG included Kawasaki disease (18
cases), immunodeficiency (3 cases), and autoimmune
conditions (6 cases, including 2 patients who had
received IVIG after rituximab-induced hypogammaglo-
bulinemia). Among the remaining 54 patients who had
not received IVIG, autoimmune/autoinflammatory con-
ditions comprised the largest group (25 patients, 46.3%);
cystic fibrosis was next most frequent (13 cases, 24.1%),
followed by acute infection (9 patients, 16.7%) and
malignancy (3 patients, 5.6%). The most frequent rheu-
matologic conditions were lupus (7 patients, 13.0%; 5
with SLE, 1 discoid lupus, and 1 minocycline-induced
lupus), polyarticular JIA (4 cases, 7.4%) and MCTD (2
cases, 3.7%). Among infectious conditions, 6 patients
had acute bacterial infections while 3 patients were pre-
sumed to have a self-limited viral process.
Conclusion
Among a cohort of patients at a large tertiary care chil-
dren’s hospital with IgG level ≥2000 mg/dL, rheumato-
logic conditions constituted a much more frequent
cause than infections. A wide variety of autoimmune
diseases were represented, although not surprisingly
lupus was the most frequent diagnosis. Interestingly, our
cohort also included a large number of cystic fibrosis
patients. The reason for hypergammaglobulinemia in
many patients is not clear, though further studies may
allow distinction between endogenous and exogenous
lymphocyte stimulation.
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Table 1 Disease categories presenting with
hypergammaglobulinemia
Diagnosis Mean IgG Meadian IgG Number (%)
Autoimmunity 2458 2200 25 (46.3)
Lupus/SLE 2693 2400 7 (13.0)
Poly JIA 2321 2337 4 (7.4)
MCTD 2230 2230 2 (3.7)
Cystic fibrosis 2147 2120 13 (24.1)
Infection 2554 2330 9 (16.7)
Malignancy 2512 2188 3 (5.6)
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